The lab of Yimon Aye, assistant professor of chemistry, has developed a new genome-wide method for identifying and analyzing proteins that could be suitable targets for drug delivery.
A conversation with Dr. Augustine M.K. Choi, who has served as the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and Cornell University’s provost for medical affairs since January 2017.
Ongoing monitoring for genetic changes in chronic lymphocytic leukemia during targeted treatment may allow clinicians to adjust patients’ treatments as the cancer evolves.
A $4 million, four-year grant will support a new research center to develop improved treatments for middle-age and older adults suffering from depression.
President Martha E. Pollack has committed the university to a new multi-institution initiative to make public data pertaining to career outcomes for life sciences doctoral students and postdoctoral researchers.
Cornell engineers have demonstrated a method for gathering vital signs using a cheap and covert system of radio-frequency signals and microchip "tags."
